Glaucoma 360: Drug delivery contact lens technology

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.

Related Videos

Related Content

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Adjusting ophthalmology practice to a pandemic

April 19th 2021

Training technology and simulation lab provides ophthalmology residents with valuable experience

January 31st 2023

Glaucoma surgical device lowers IOP level

January 30th 2023

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Adjusting ophthalmology practice to a pandemic

April 19th 2021

Training technology and simulation lab provides ophthalmology residents with valuable experience

January 31st 2023

Glaucoma surgical device lowers IOP level

January 30th 2023

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

February 3rd 2023

Modifying and optimizing a new era of glaucoma surgeries

May 31st 2021

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Adjusting ophthalmology practice to a pandemic

April 19th 2021

Training technology and simulation lab provides ophthalmology residents with valuable experience

January 31st 2023

Glaucoma surgical device lowers IOP level

January 30th 2023

Related Content

---

Glaucoma 360: Drug targets and reduces episcleral venous pressure in glaucoma

Article

---

Modifying and optimizing a new era of glaucoma surgeries

Podcast

---

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

Article

---

Adjusting ophthalmology practice to a pandemic

Podcast

---

Training technology and simulation lab provides ophthalmology residents with valuable experience

Article

---

Glaucoma surgical device lowers IOP level

Article